28 related articles for article (PubMed ID: 17785579)
1. Computational prediction and in vitro validation of VEGFR1 as a novel protein target for 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Chitrala KN; Yang X; Busbee B; Singh NP; Bonati L; Xing Y; Nagarkatti P; Nagarkatti M
Sci Rep; 2019 May; 9(1):6810. PubMed ID: 31048752
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanisms of the SLC13A5 Gene Transcription.
Li Z; Wang H
Metabolites; 2021 Oct; 11(10):. PubMed ID: 34677420
[TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
Hanieh H
Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
[TBL] [Abstract][Full Text] [Related]
4. Mammalian cytochrome P450-dependent metabolism of polychlorinated dibenzo-p-dioxins and coplanar polychlorinated biphenyls.
Inui H; Itoh T; Yamamoto K; Ikushiro S; Sakaki T
Int J Mol Sci; 2014 Aug; 15(8):14044-57. PubMed ID: 25123135
[TBL] [Abstract][Full Text] [Related]
5. Pregnane-x-receptor controls hepatic glucuronidation during pregnancy and neonatal development in humanized UGT1 mice.
Chen S; Yueh MF; Evans RM; Tukey RH
Hepatology; 2012 Aug; 56(2):658-67. PubMed ID: 22371261
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.
Zhang S; Kim K; Jin UH; Pfent C; Cao H; Amendt B; Liu X; Wilson-Robles H; Safe S
Mol Cancer Ther; 2012 Jan; 11(1):108-18. PubMed ID: 22034498
[TBL] [Abstract][Full Text] [Related]
7. Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.
Klein K; Winter S; Turpeinen M; Schwab M; Zanger UM
Front Pharmacol; 2010; 1():129. PubMed ID: 21918647
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human UGT2B7 gene expression in transgenic mice by the constitutive androstane receptor.
Yueh MF; Mellon PL; Tukey RH
Mol Pharmacol; 2011 Jun; 79(6):1053-60. PubMed ID: 21415305
[TBL] [Abstract][Full Text] [Related]
9. Dioxin increases the interaction between aryl hydrocarbon receptor and estrogen receptor alpha at human promoters.
Ahmed S; Valen E; Sandelin A; Matthews J
Toxicol Sci; 2009 Oct; 111(2):254-66. PubMed ID: 19574409
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-373 induces expression of genes with complementary promoter sequences.
Place RF; Li LC; Pookot D; Noonan EJ; Dahiya R
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1608-13. PubMed ID: 18227514
[TBL] [Abstract][Full Text] [Related]
11. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells.
Nakajima M; Iwanari M; Yokoi T
Toxicol Lett; 2003 Sep; 144(2):247-56. PubMed ID: 12927368
[TBL] [Abstract][Full Text] [Related]
12. Conserved genomic structure of the Cyp1a1 and Cyp1a2 loci and their dioxin responsive elements cluster.
Nukaya M; Bradfield CA
Biochem Pharmacol; 2009 Feb; 77(4):654-9. PubMed ID: 19026991
[TBL] [Abstract][Full Text] [Related]
13. Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm.
Nebert DW; Petersen DD; Fornace AJ
Environ Health Perspect; 1990 Aug; 88():13-25. PubMed ID: 2272308
[TBL] [Abstract][Full Text] [Related]
14. A dioxin-responsive enhancer 3' of the human CYP1A2 gene.
Okino ST; Quattrochi LC; Pookot D; Iwahashi M; Dahiya R
Mol Pharmacol; 2007 Dec; 72(6):1457-65. PubMed ID: 17785579
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells: CYP1A2 expression in the LS180 colon carcinoma cell line after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 3-methylcholanthrene.
Li W; Harper PA; Tang BK; Okey AB
Biochem Pharmacol; 1998 Sep; 56(5):599-612. PubMed ID: 9783729
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the mouse Cyp1B1 gene. Identification of an enhancer region that directs aryl hydrocarbon receptor-mediated constitutive and induced expression.
Zhang L; Savas U; Alexander DL; Jefcoate CR
J Biol Chem; 1998 Feb; 273(9):5174-83. PubMed ID: 9478971
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
